Effect of Ezetimibe Coadministered With Atorvastatin in 628 Patients With Primary Hypercholesterolemia
Top Cited Papers
- 20 May 2003
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 107 (19), 2409-2415
- https://doi.org/10.1161/01.cir.0000068312.21969.c8
Abstract
Background— Despite the established efficacy of statins, many patients do not achieve recommended LDL cholesterol (LDL-C) goals. Contributing factors may be inadequate dosing, increased risk for adverse effects with high-dose monotherapy, and increased potential for intolerance and adverse effects with combinations of available agents.Keywords
This publication has 18 references indexed in Scilit:
- Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemiaJournal of the American College of Cardiology, 2002
- Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemiaThe American Journal of Cardiology, 2002
- Achieving and maintaining national cholesterol education program low-density lipoprotein cholesterol goals with five statinsAmerican Journal Of Medicine, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- A Comparison of Simvastatin and Atorvastatin up to Maximal Recommended Doses in a Large Multicenter Randomized Clinical TrialCurrent Medical Research and Opinion, 2001
- The Lipid Treatment Assessment Project (L-TAP)Archives of Internal Medicine, 2000
- Drug Treatment of Lipid DisordersNew England Journal of Medicine, 1999
- Effects of high doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-IThe American Journal of Cardiology, 1999
- Antihyperlipidaemic AgentsDrug Safety, 1994
- Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)JAMA, 1993